Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combined treatment modality in small cell lung cancer : the impact of radiotherapy on survival.

× No keyword cloud information.

10 in total

1. Cisplatin or carboplatin? Neutrophil to lymphocyte ratio may serve as a useful factor in small cell lung cancer therapy selection.

Authors: Zhangchi Pan; Lu Zhang; Chen Liu; Xiaobing Huang; Songfei Shen; Xiaoyan Lin; Chunmei Shi
Journal: Oncol Lett Date: 2019-06-07 Impact factor: 2.967

Review 2. [Concurrent radiochemotherapy for the treatment of solid tumors].

Authors: R Fietkau
Journal: Strahlenther Onkol Date: 2012-11 Impact factor: 3.621

3. Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Authors: Dirk Rades; Cornelia Setter; Juergen Dunst; Olav Dahl; Steven E Schild; Frank Noack
Journal: Strahlenther Onkol Date: 2010-04-26 Impact factor: 3.621

4. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.

Authors: F Manapov; S Klöcking; M Niyazi; C Belka; G Hildebrandt; R Fietkau; G Klautke
Journal: Strahlenther Onkol Date: 2011-12-23 Impact factor: 3.621

5. Comparison of the effectiveness of "late" and "early" prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.

Authors: Beata Sas-Korczyńska; Stanisław Korzeniowski; Ewa Wójcik
Journal: Strahlenther Onkol Date: 2010-05-21 Impact factor: 3.621

6. Small cell carcinoma of vulva: curative multimodal treatment in face of resistance to initial standard chemotherapy.

Authors: Franziska Eckert; Tanja Fehm; Michael Bamberg; Arndt-Christian Müller
Journal: Strahlenther Onkol Date: 2010-08-30 Impact factor: 3.621

7. Correlation of patient-related factors and dose-volume histogram parameters with the onset of radiation pneumonitis in patients with small cell lung cancer.

Authors: Falk Roeder; Jochen Friedrich; Carmen Timke; Jutta Kappes; Peter Huber; Robert Krempien; Juergen Debus; Marc Bischof
Journal: Strahlenther Onkol Date: 2010-02-22 Impact factor: 3.621

8. Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.

Authors: Karl Wurstbauer; Florian Merz; Felix Sedlmayer
Journal: Strahlenther Onkol Date: 2009-08-04 Impact factor: 3.621

9. Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches.

Authors: Ting Mei; Weigang Xiu; Xuexi Yang; Xiaoman Tian; Yang Yu; Yong Xu; Lin Zhou; Xiaojuan Zhou; Yongmei Liu; Bingwen Zou; Jianxin Xue; Rui Ao; You Lu; Youling Gong
Journal: Strahlenther Onkol Date: 2021-04-28 Impact factor: 3.621

10. Serum expression level of IL-6 at the diagnosis time contributes to the long-term prognosis of SCLC patients.

Authors: Xi Ding; Jie Zhang; Di Liu; Wen Xu; De-Yi Lu; Li-Ping Zhang; Bo Su
Journal: J Cancer Date: 2018-02-11 Impact factor: 4.207

10 in total